Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

2018/11/29 by Stergios A. Polyzos, Stergios A. Pοlyzos, Jannis Kountouras +2 · 6 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Liver Disease Diagnosis and Treatment #Diet, Metabolism, and Disease #Metabolism, Diabetes, and Cancer

paper · doi:10.1016/j.metabol.2018.11.014

Citations

• Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
• The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
• Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease

Cited by

• The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis
• Adiponectin and leptin in the diagnosis and therapy of NAFLD
• The Therapeutic Potential of Theobromine in Obesity: A Comprehensive Review
• Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
• Sarcopenia and MASLD: novel insights and the future
• Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease